Bill > S7028

Introduced Session

An act relating to cancer; amending s. 381.915, F.S.; revising the definitions of the terms “cancer center” and “Florida-based”; defining the term “Cancer Connect Collaborative” or “collaborative”; making clarifying changes; deleting an obsolete date; revising the composition of the collaborative; deleting obsolete provisions; requiring the collaborative to review all submitted Cancer Innovation Fund grant applications using certain parameters; requiring the collaborative to give priority to certain applications; requiring licensed or certified health care providers, facilities, or entities to meet certain criteria to be eligible for specified grant funding; specifying such criteria; requiring the Department of Health to appoint peer review panels for a specified purpose; requiring that priority scores be forwarded to the collaborative and be considered in determining which proposals the collaborative recommends for certain grant funding; requiring the collaborative and peer review panels to establish and follow certain guidelines and adhere to a certain policy; prohibiting a member of the collaborative or a panel from participating in certain discussions or decisions under certain circumstances; requiring, beginning on a specified date and annually thereafter, the collaborative to prepare and submit a specified report to the Governor and the Legislature; requiring that the report include certain information; revising the requirements for a specified report by the department; requiring, beginning on a specified date, that certain allocation agreements include certain information; providing legislative findings; creating the Cancer Connect Collaborative Research Incubator within the department, and overseen by the collaborative, to provide funding for a specified purpose over a specified timeframe; specifying the incubator’s targeted area of cancer research for the first specified timeframe; providing that grants issued through the incubator are contingent upon the appropriation of funds and must be awarded through a specified process; requiring that priority be given to certain applicants; authorizing the prioritization of certain grant proposals; providing that applications for incubator funding may be submitted by specified hospitals; requiring that all qualified applicants have equal access and opportunity to compete for research funding; requiring that incubator grants be recommended by the collaborative and awarded by the department in a certain manner; requiring the department to appoint peer review panels for a specified purpose; requiring that priority scores be forwarded to the collaborative and be considered in determining which proposals the collaborative recommends for funding; requiring the collaborative and peer review panels to establish and follow certain guidelines and adhere to a certain policy; prohibiting a member of the collaborative or a panel from participating in certain discussions or decisions; requiring recipients of incubator grant funds to enter into an allocation agreement with the department; specifying requirements for such allocation agreements; requiring, beginning on a specified date and annually until a specified date, the collaborative to prepare and submit a specified report to the Governor and the Legislature; requiring the collaborative to make a certain recommendation under certain circumstances; requiring that a specified report include certain information; amending s. 381.922, F.S.; establishing the Bascom Palmer Eye Institute VisionGen Initiative within the William G. “Bill” Bankhead, Jr., and David Coley Cancer Research Program; providing the purpose of the initiative; providing that funding for the initiative is subject to annual appropriation; providing an effective date.

No sponsors listed

Other Sponsors (1)

Died in Messages, companion bill(s) passed, see SB 2514 (Ch. 2025-204) (on 06/16/2025)

Official Document